Equibles does not estimate personal net worth.
Get an email with a short summary when Emergent BioSolutions Inc. publishes a filing, an earnings call transcript or a press release.
Get EBS alertsFrank Vargo is recorded as CFO at Emergent BioSolutions Inc. (EBS) since January 1, 2027. Emergent BioSolutions Inc. reported in an 8-K filed October 16, 2026 that Frank Vargo was appointed Interim Chief Financial Officer, effective January 1, 2027. Frank Vargo has spoken on 3 earnings calls across 1 company, most recently for Emergent BioSolutions Inc. on November 2, 2026. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.
“Frank Vargo, vice president, treasurer, will assume the role of interim chief financial officer effective January 1, 2027.”
“Good afternoon, everyone, and thank you for joining us as Emergent discusses its operational and financial results for the third quarter of 2026. As is customary, today's call is open to all participants, it's being recorded, and it's copyrighted by Emergent Bias Solutions.”
“Good afternoon, everyone, and thank you for joining us as Emergent discusses its operational and financial results for the second quarter of 2026. As is customary, today's call is open to all participants, is being recorded, and is copyrighted by Emergent BioSolutions.”
“So, I think I got all three of you, but is that even the outcome? Okay, I'll take that as we got all of it.”
2027-01-01–present
Source not stated
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2027-01-01–present
